Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control - Glynne-Jones, R; Counsell, N; Quirke, P (Ann Oncol, 2014)
, et al.